These results indicated that combined treatment of MPSE with IR regulated the PI3K/AKT and MAPK signaling pathways in breast cancer cells to enhance IR’s efficacy, affecting cell survival, migration, and apoptosis. The gene discussed is AKT1; the disease is breast carcinoma.